Pasithea Therapeutics Corp. (KTTA) NASDAQ

2.81

+0.67(+31.31%)

Updated at February 05 03:31PM

Currency In USD

Valuation

Market Cap9.34M
Enterprise Value-6.91M
P/E Ratio-0.21
PEG Ratio0
Price/Sales Ratio4.11
Price/Book Ratio0.19
Enterprise/Revenue-5.52
Enterprise/EBITDA0.35

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-16.16
Operating Margin-16.53

Management Effectiveness

Return On Assets-0.85
Return On Equity-0.82

Income Statement

Revenue0
Revenue/Share0.94
Gross Profit-648,454
EBITDA-15.33M
Net Income-15.96M
Diluted EPS-13.01

Balance Sheet

Total Cash9.36M
Total Cash/Share8.97
Total Debt0
Total Debt/Equity0
Current Ratio14.81
Book Value Per Share17.06

Price History

52-Week Change-50.78
52-Week High9.25
52-Week Low2.04
Moving Average 50 Days2.74
Moving Average 200 Days4.58

Statistics

Average Volume44,330
Shares Outstanding1.27M
% Held by Institutions0.99

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateJanuary 02, 2024